Home › NDC Lookup › RxCUI directory › RxCUI 1361023

Phentolamine mesylate 5 MG Injection — RxCUI 1361023

Name: Phentolamine mesylate 5 MG Injection (RxCUI 1361023)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1361023 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1361023

Official namePhentolamine mesylate 5 MG Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped2

Package NDCs mapped3

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Phentolamine mesylate 5 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Phentolamine mesylate 5 MG Injection RxCUI 1361023 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Phentolamine 8153 IN
- Phentolamine mesylate 227240 PIN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Phentolamine Injection 1856563 SCDF
- Phentolamine mesylate Injection 2645572 SCDFP
- Phentolamine Injectable Product 1157570 SCDG
- Phentolamine mesylate Injectable Product 2661814 SCDGP
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 1

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Phentolamine mesylate 5 MG 1856562 SCDC

Showing up to 8 concepts per family — 9 of 9 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Phentolamine mesylate 5 MG SCDC · 1856562
Phentolamine Injection SCDF · 1856563
Phentolamine mesylate Injection SCDFP · 2645572
Phentolamine Injectable Product SCDG · 1157570
Phentolamine mesylate Injectable Product SCDGP · 2661814

📦 FDA Products & Package NDCs

2 products · 3 package NDCs

3 package NDCs map to RxCUI 1361023 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9564-01	1 VIAL in 1 BOX (0143-9564-01) / 1 mL in 1 VIAL	Phentolamine Mesylate	Hikma Pharmaceuticals USA Inc.	2015-11-04
00143-9564-10	10 VIAL in 1 BOX (0143-9564-10) / 1 mL in 1 VIAL	Phentolamine Mesylate	Hikma Pharmaceuticals USA Inc.	2015-11-04
68094-0101-20	1 VIAL in 1 CARTON (68094-101-20) / 1 INJECTION in 1 VIAL	PHENTOLAMINE MESYLATE	Precision Dose Inc.	2017-07-15

Observed labelers: Hikma Pharmaceuticals USA Inc. (2) · Precision Dose Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J2760	Phentolaine mesylate inj	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.